Variables | Total (%) | 30-day mortality (%) | Long-term death (%) | |||||
---|---|---|---|---|---|---|---|---|
Yes | No | P value | Yes | No | P value | |||
Preoperative variables | ||||||||
Age ≥ 50 (years) | 36 (24.66) | 7 (4.79) | 29 (19.86) | 0.047 | 10 (6.85) | 26 (17.81) | 0.051 | |
BMI ≥ 30 (Kg/m2) | 13 (8.90) | 0 (0) | 13 (8.90) | 0.461 | 1 (0.68) | 12 (8.22) | 0.575 | |
Male | 111 (76.03) | 13 (8.90) | 98 (67.12) | 0.222 | 19 (13.01) | 92 (63.01) | 0.997 | |
Current smoking | 59 (40.41) | 5 (3.42) | 54 (36.99) | 0.706 | 12 (8.22) | 47 (32.19) | 0.396 | |
Hypertension | 80 (54.79) | 9 (6.16) | 71 (48.63) | 0.453 | 18 (12.33) | 62 (42.47) | 0.058 | |
Peripheral vascular disease | 14 (9.59) | 0 (0) | 14 (9.59) | 0.421 | 1 (0.68) | 13 (8.90) | 0.503 | |
Prior cardiac surgery | 30 (20.55) | 1 (0.68) | 29 (19.86) | 0.338 | 4 (2.74) | 26 (17.81) | 0.536 | |
Prior TEVAR | 24 (16.44) | 3 (2.05) | 21 (14.38) | 0.880 | 5 (3.42) | 19 (13.01) | 0.817 | |
Prior open repair of TAAAR | 3 (2.05) | 0 (0) | 3 (2.05) | 1.000 | 2 (1.37) | 1 (0.68) | 0.076 | |
Marfan syndrome | 39 (26.71) | 5 (3.42) | 34 (23.29) | 0.629 | 7 (4.79) | 32 (21.92) | 0.873 | |
Aortic aneurysm | 134 (91.78) | 11 (7.53) | 123 (84.25) | 0.167 | 22 (15.07) | 112 (76.71) | 0.722 | |
Aortic dissection | 107 (73.29) | 11 (7.53) | 96 (65.75) | 0.879 | 18 (12.33) | 89 (60.96) | 0.873 | |
CAD | 5 (3.42) | 1 (0.68) | 4 (2.74) | 0.400 | 2 (1.37) | 3 (2.05) | 0.203 | |
Stroke | 6 (4.11) | 0 (0) | 6 (4.11) | 1.000 | 0 (0) | 6 (4.11) | 0.559 | |
Chronic renal insufficiency | 22 (15.07) | 0 (0) | 22 (15.07) | 0.206 | 3 (2.05) | 19 (13.01) | 0.870 | |
Carotid artery diseases | 17 (11.64) | 5 (3.42) | 12 (8.22) | 0.012 | 5 (3.42) | 12 (8.22) | 0.276 | |
Rupture | 3 (2.05) | 1 (0.68) | 2 (1.37) | 0.263 | 1 (0.68) | 2 (1.37) | 0.433 | |
ASA | 0.822 | 0.478 | ||||||
Class I, II and III | 113 (77.40) | 10 (6.85) | 103 (70.55) | 18 (12.33) | 95 (65.07) | |||
Class IV | 33 (22.60) | 4 (2.74) | 29 (19.86) | 7 (4.79) | 26 (17.81) | |||
NYHA | 0.216 | 0.833 | ||||||
Class I and II | 133 (91.10) | 11 (7.53) | 122 (83.56) | 22 (15.07) | 111 (76.03) | |||
Class III and IV | 13 (8.90) | 3 (2.05) | 10 (6.85) | 3 (2.05) | 10 (6.85) | |||
Maximum aneurysm diameter (cm) | 5.83 ± 2.24 | 4.68 ± 2.65 | 5.95 ± 2.17 | 0.105 | 5.58 ± 2.54 | 5.88 ± 2.18 | 0.637 | |
Hemoglobin<120 (g/L) | 16 (10.96) | 2 (1.37) | 14 (9.59) | 1.000 | 3 (2.05) | 13 (8.90) | 1.000 | |
RBC<3.5 (1012/L) | 7 (4.79) | 1 (0.68) | 6 (4.11) | 0.514 | 2 (1.37) | 5 (3.42) | 0.757 | |
Albumin<35 (g/L) | 14 (9.59) | 2 (1.37) | 12 (8.22) | 0.880 | 3 (2.05) | 11 (7.53) | 0.939 | |
HCT<0.35 (%) | 39 (26.71) | 5 (3.42) | 34 (23.29) | 0.629 | 7 (4.79) | 32 (21.92) | 0.873 | |
Intraoperative variables | ||||||||
Non-elective surgery | 6 (4.11) | 1 (0.68) | 5(3.42) | 0.460 | 2 (1.37) | 4 (2.74) | 0.601 | |
Preoperative CSFD | 41 (28.08) | 4 (2.74) | 37 (25.34) | 1.000 | 7 (4.79) | 34 (23.29) | 0.992 | |
Fluid volume (ml) | 2836.07 ± 1586.00 | 4463.21 ± 2583.95 | 2663.49 ± 1344.87 | 0.014 | 3763.40 ± 2337.18 | 2644.47 ± 1315.59 | 0.069 | |
ACC time (min) | 22.29 ± 24.04 | 33.86 ± 33.84 | 21.06 ± 22.59 | 0.434 | 34.88 ± 32.75 | 19.69 ± 21.07 | 0.041 | |
DHCA | 7 (4.79) | 2 (1.37) | 5 (3.42) | 0.136 | 3 (2.05) | 4 (2.74) | 0.181 | |
Bleeding volume (ml) | 1543.78 ± 1237.73 | 2450.00 ± 1746.42 | 1447.67 ± 1138.40 | 0.010 | 2028.00 ± 1474.30 | 1443.74 ± 1165.11 | 0.014 | |
Volume of RBC (units) | 4.36 ± 6.11 | 14.79 ± 9.58 | 3.26 ± 4.40 | <0.001 | 9.16 ± 9.69 | 3.37 ± 4.53 | 0.008 | |
Volume of plasma (ml) | 738.38 ± 897.66 | 2000.00 ± 1619.12 | 604.57 ± 666.04 | 0.001 | 1416.00 ± 1399.90 | 598.37 ± 682.86 | 0.003 | |
Volume of platelet (units) | 2.32 ± 0.86 | 2.43 ± 1.45 | 2.30 ± 0.78 | 0.316 | 2.32 ± 1.11 | 2.31 ± 0.81 | 0.758 | |
Use of norepinephrine | 46 (31.51) | 11 (7.53) | 35 (23.97) | <0.001 | 14 (9.59) | 32 (21.92) | 0.004 | |
Use of epinephrine | 10 (6.85) | 6 (4.11) | 4 (2.74) | <0.001 | 7 (4.79) | 3 (2.05) | <0.001 | |
Use of dopamine | 76 (52.05) | 11(7.53) | 65 (44.52) | 0.037 | 18 (12.33) | 58 (39.73) | 0.028 |